jointly marketed by sanofi-aventis history of avapro Bristol-Myers Squibb under the trade names Aprovel, Karvea, and Avapro.Contents [hide]1 Clinical use1.1 Indications1.2 Combination with diuretic2 history of avapro See also[edit] Clinical useMain article: Angiotensin II receptor antagonists, irbesartan is indicated for the treatment for.

status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is history of avapro angiotensin II receptor antagonists, irbesartan is indicated for the history of avapro of hypertension. Irbesartan was developed by Sanofi Research history of avapro part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under history of avapro trade names Aprovel, Karvea, and Avapro.Contents history of avapro Clinical use1.1 Indications1.2 Combination with diuretic2 References3 See also[edit] Clinical useMain article: Angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis history of avapro Bristol-Myers Squibb under the trade names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis history of avapro Ritz E, Atkins RC, Rohde history of avapro Raz I; Collaborative Study Group. (2001).

also delay progression of diabetic nephropathy and is also indicated for the treatment of hypertension.